Zhimeng Biopharma EN | 简体
Zhimeng Biopharma
  • Home
  • About Us
  • People
    • Leadership Team
    • Scientific Advisors
  • Pipeline
  • News
  • Investors
  • Join Us
  • Contact

People

Leadership Team

Huanming Chen, Ph.D.

Huanming Chen, Ph.D.

President and CEO
Zhijun Zhang, Ph.D.

Zhijun Zhang, Ph.D.

Bo Liang, Ph.D.

Bo Liang, Ph.D.

Vice President of Chemistry

Get in touch

Contact Us About Us Leadership Team Scientific Advisors
Quick Links
  • About Us
  • Contact Us
  • Join Us
  • Pipeline
  • Leadership Team
  • Scientific Advisors
Recent News
  • Zhimeng Biopharma Entered into A Global Exclusive Licensing Agreement with GlaxoSmithKline in HBV
  • Zhimeng Biopharma Announces Dosing of First Subject in Phase II Clinical Trial of Its Novel HBV Capsid Assembly Modulator
  • Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial
  • Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase I Clinical Trial of CB06

© 2023 Zhimeng Biopharma. All Rights Reserved. 备案号:沪ICP备18045542号-1 | 沪公网安备 31011502011190号

© 2023 Zhimeng Biopharma. All Rights Reserved.